|
|
||||||||
1 Charles A. Dana Research Institute and Harvard-Thorndike Laboratory of Beth Israel Hospital, 2 Beth Israel Hospital Sleep Disorders Center, and 3 Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215
Launois, Sandrine H., Judy Tsui, and J. Woodrow Weiss.
Respiratory function of velopharyngeal constrictor muscles during wakefulness in normal adults. J. Appl.
Physiol. 82(2): 584-591, 1997.
The levator veli
palatini (LVP) and the superior pharyngeal constrictor (SPC) influence
velopharyngeal patency and soft palate position, but their behavior
during respiration is incompletely characterized. To further clarify
their respiratory function, we recorded electromyographic activity
(EMG) in the LVP and the SPC in awake normal subjects breathing orally.
EMG data were obtained in six subjects for the LVP and in nine subjects
for the SPC. EMG activity and timing and ventilation were measured
during isocapnic hypoxia and hyperoxic hypercapnia. Phasic EMG activity
was inconsistently present during unstimulated oral breathing. Timing
of EMG phasic activity was variable for both muscles. Peak LVP activity
was mainly or exclusively expiratory in three of six subjects. Peak SPC
activity was mainly or exclusively expiratory in five of nine subjects.
With chemostimulation, recruitment of phasic activity was observed in
the LVP in four of six subjects and in the SPC in five of nine
subjects. Tonic activity increased in four of six subjects for the LVP
and in three of nine subjects for the SPC. However, the response was
alinear, and intersubject as well as breath-to-breath variability was
substantial. In conclusion, LVP and SPC are characterized by the high
inter- and intrasubject variability of EMG activity, timing of
activation, and response to chemostimulation.
upper airway; soft palate; levator veli palatini; superior
pharyngeal constrictor; respiration; chemostimulation; electromyography
THE IMPORTANCE of the velopharyngeal region in the
pathophysiology of sleep-disordered breathing has been amply
demonstrated. In awake normal subjects as well as sleep apnea patients,
the retropalatal region is the narrowest pharyngeal segment during nasal breathing (24). Although collapse can occur in the oropharynx or
in the hypopharynx, the velopharynx is frequently a primary site of
obstruction during sleep in apneic patients, and transpalatal resistance increases with sleep onset in >50% of normal men (10, 19). In addition, narrowing at the velopharyngeal level may precipitate
oro- or hypopharyngeal collapse. Velopharyngeal mechanics are
controlled by nonneuromuscular factors such as lung volume and by the
activity of the velopharyngeal musculature. The contribution of
constrictor muscles to the pathophysiology of sleep-induced changes in
upper airway dynamics has received little attention. These muscles play
a fundamental role in nonrespiratory functions of the upper airway.
Soft palate position is regulated by complex interactions between
velopharyngeal constrictor muscles, the levator veli palatini (LVP) and
the superior pharyngeal constrictor (SPC), and velopharyngeal dilator
muscles, the palatopharyngeus and palatoglossus (7, 13). The
respiratory function of the LVP and SPC has not been investigated in
detail, but respiratory-related activity has been recorded in both
muscles. The SPC exhibits phasic expiratory activity during wakefulness
in normal adults during forceful breathing, although no data are
available during tidal breathing (23). The LVP respiratory-related
activity appears to be more variable: some authors failed to record any
phasic activity (8, 12), whereas others demonstrated that phasic
activity can be inspiratory, expiratory, or variable and is strongly
dependent on the route of breathing (6, 18, 20, 27). Regardless of the
phase pattern, tonic and phasic electromyographic (EMG) activity in both muscles are likely to affect velopharyngeal dimensions
substantially. To clarify LVP and SPC respiratory function, we recorded
their EMG activity in 10 normal adults during wakefulness and assessed their response to hypoxia and hypercapnia.
Subjects
Table 1.
Subject characteristics
Subject No.
Sex
Age, yr
BMI,
kg/m2
E/PETCO2,
l · min
1 · Torr
1
E/SaO2,
l · min
1 · %
1
1
M
24
23.8
0.93
0.14
2
F
22
20.4
1.50
0.25
3
M
31
22.3
0.95
0.39
4
F
31
23.2
2.77
0.13
5
F
38
22.1
2.96
1.21
6
M
33
20.3
1.47
1.30
7
F
19
18.9
1.19
0.84
8
M
31
26.6
1.22
1.12
9
F
26
22.1
1.06
0.17
10
M
28
22.4
2.71
0.81
Mean ± SD
28.3 ± 5.7
22.2 ± 2.1
1.68 ± 0.81
0.64 ± 0.47
M, male; F, female; BMI, body mass index;
E, minute ventilation;
PETCO2, end-tidal
PCO2; SaO2,
arterial O2 saturation.
Measurements
Respiration. Subjects were connected to a bag in a box via a unidirectional breathing circuit. Route of breathing was fixed to oral breathing through a mouthpiece connected to the breathing circuit. Nose clips were used to prevent nasal airflow. Airflow was measured with a wedge spirometer (Med Science 500), and the flow signal was integrated to obtain volume (8815A Respiratory integrator, Hewlett-Packard). Arterial oxygen saturation (SaO2) was monitored with a pulse oximeter (Ohmeda 3700) by using a finger probe. End-tidal PCO2 (PETCO2) was measured at the mouth by a mass spectrometer (MGA-1100, Perkin-Elmer Medical Instruments). EMG. LVP and SPC EMGs were recorded from bipolar fine-wire electrodes (Teflon-coated stainless steel wire, 0.08 mm, Medwire). A 4% lidocaine spray was applied to the oropharynx and the oral side of the soft palate. LVP electrodes were inserted by using a 1.5-in. 24-gauge sterile needle bent at the distal third to a 30° angle and attached to an empty 12-ml syringe. While the subject sustained the sound "aah," the needle tip was inserted laterocranioposteriorly ~10 mm in the "levator dimple" (8). SPC electrodes were inserted by using a 0.75-in. 23-gauge sterile needle bent at midpoint to a 90° angle and attached to an empty 12-ml syringe. The needle was inserted ~2 mm under the mucosal surface of the posterior pharyngeal wall, midway between the level of the soft palate margin and the level of the tongue base (9). After removal of the placement needles, wires were taped securely to the face and attached to copper spring clips soldered to the free ends of amplifier lead-in wires. A grounding electrode was placed on the forehead. EMG signals were preamplified and band-passed filtered between 30 and 1,000 Hz with battery-powered differential amplifiers (Grass P15D) and further amplified (Tektronix TM 504) before being full-wave rectified and electronically integrated with a leak time constant of 150 ms. Once in place, the electrodes did not cause any discomfort. Recordings. PETCO2, SaO2, raw and integrated EMG signals, integrated tidal volume, and airflow were displayed on a chart recorder (Hewlett-Packard 7758B) at a paper speed of 5 mm/s for subsequent analysis.Experimental Protocol
Subjects were studied on a single occasion while they were awake. They were asked to refrain from caffeinated beverages 12 h before the study. After EMG electrode placement, subjects were seated in a specially designed chair that fixes body and head position. Correct electrode position was ascertained by observing bursts of EMG activity while the subject swallowed and produced a sustained "aah." Furthermore, several bursts of activity were observed during the production of two test sentences: "I do not think so" and "The boot belongs to my father" (7). The experimental protocol started at least 30 min after application of topical anesthesia. EMG responses to hyperoxic hypercapnia and to isocapnic hypoxia were assessed (21, 22). Two consecutive trials were performed for each chemostimulation, separated by 10-min rest periods. Electrical zero and system zero (defined by shorting the amplifier inputs) were verified immediately before and after each trial. Before the study was terminated and the electrodes were removed, the soft palate and oropharynx were inspected to confirm that all wires had remained in place.Data Analysis
Chemoresponse was measured twice for each stimulus. Results from both trials were combined and used for analysis. Because of poor signals related to technical problems, data from one of the two trials were rejected in four cases (subjects 5 and 8-10) for the hypoxic challenge and in one case (subject 7) for the hypercapnic challenge.EMG signals were obtained in 6 of 10 subjects for the LVP and in 9 of 10 subjects for the SPC. In subject 1, one wire was dislodged during the first hypoxic challenge, and SPC EMG signal during hypoxia could not be analyzed.
The integrated signal was used to quantify EMG activity. Electrical and system baselines did not change throughout the study, and thus electrical zero was used as the reference for measurements. EMG activity was expressed as a percentage of the maximum respiratory-related activity observed during the four trials. Most subjects displayed maximum respiratory activity during hypercapnia for both muscles. Tonic activity was defined as the minimum EMG value and phasic activity as the difference between the maximum EMG value and the tonic activity.
Breaths with unequivocal monophasic activity were selected for
phase-pattern analysis. For each subject, 10-46 breaths were selected and grouped on the basis of the levels of chemostimulation: normoxic normocapnia (SaO2 >95%,
PETCO2
45 Torr); normoxic mild hypercapnia (SaO2
>95%, PETCO2
56 Torr);
normoxic moderate hypercapnia (SaO2
>95%, PETCO2 >56 Torr);
normocapnic mild hypoxia (SaO2
95%,
PETCO2
45
Torr); and normocapnic moderate hypoxia
(SaO2
89%,
PETCO2
45 Torr). For each sample, the number of breaths with monophasic EMG activity varied from
0 to 21. The relationship between EMG activity and the respiratory cycle was analyzed for each of these five groups. Timing of peak EMG
activity was determined for the selected breaths. Peak activity was
considered predominantly expiratory or predominantly inspiratory if it
was measured during expiration or inspiration, respectively, in >50%
of the selected breaths.
The relationship between EMG activity and
PETCO2 and between EMG
activity and SaO2 was
tested by using the least squares method. For statistical analysis as
well as graphic representation (see Figs. 2, 3, 4, 5), phasic and tonic
activity for each breath, regardless of its inspiratory or expiratory
nature, were considered and data from the two trials were combined. A
P value of 0.05 or less was considered
significant. Data are presented as means ± SD.
Ventilatory Response to Chemical Stimulation
Ventilatory responses to isocapnic hypoxia ranged from
0.13 to
1.30
l · min
1 · % SaO2
1
and to hyperoxic hypercapnia from 0.93 to 2.96 · min
1 · Torr
1
(Table 1). The mean maximum minute ventilations achieved during the
hypoxic and hypercapnic challenges were 32.6 ± 14.6 and
54.2 ± 20.4 l/min, respectively.
EMG Activity During Quiet Breathing
EMG activity was analyzed at the beginning of each trial, during quiet oral breathing with nose clips. Phasic activity was present in the LVP in three subjects (subjects 2, 3, and 5) during two of the four normocapnic normoxic periods. Subject 5 consistently exhibited SPC phasic EMG activity during quiet breathing. In addition, five subjects (subjects 2, 4, and 7-9) showed SPC phasic activity during at least one of the four periods.Timing of EMG Phasic Activity
LVP peak activity occurred mainly or exclusively during inspiration in subject 1 and during expiration in subject 2. SPC peak activity occurred mainly or exclusively during inspiration in subject 8 and during expiration in subjects 6 and 10. In all other cases, phase-pattern timing varied with the sample considered. However, we did not observe any trend that could suggest that the nature or intensity of the chemostimulation explained the variability in timing (Table 2). When the five samples were averaged, LVP peak activation was mainly inspiratory in one-half of the subjects, and SPC peak activation was mainly expiratory in five of nine subjects (Table 3).
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
In all subjects, and for both muscles, a biphasic discharge pattern was
observed occasionally for a single breath. In subject 8, a consistent biphasic pattern was noted in the LVP
during hypoxia but not during hypercapnia. In subject
3, LVP was phasically active during expiration and
inspiration during the first hypoxic challenge. With progressive
hypoxia, inspiratory activity increased, whereas expiratory bursts of
EMG activity disappeared (Fig. 1).
LVP Response to Chemical Stimulation
Subjects 1-3 and 10 showed a significant increase in LVP phasic activity as PETCO2 rose (P < 0.01). In subject 5, phasic activity was present in the LVP at the beginning of the trials and progressively disappeared as PETCO2 increased. In subject 8, LVP phasic activity increased significantly with hypercapnia once PETCO2 had reached 48 Torr (P = 0.0001). LVP tonic activity increased significantly with PETCO2 in subjects 1 and 10 (P = 0.0001) and remained unchanged in subjects 2, 3, and 8. In subject 5, tonic activity increased between 45 and 54 Torr, decreased sharply when phasic activity started to decline, and remained stable until the end of the challenge. Phasic LVP EMG activity increased with hypoxia in subjects 3, 8, and 10 (P
0.02) and decreased in subjects 1 and 5 (P < 0.001) (Fig. 2). In subject
2, progressive hypoxia was accompanied by an increase in phasic LVP activity during the first trial and a decrease in activity during the second trial. LVP tonic activity increased significantly with progressive hypoxia in subjects
3, 8, and
10 and decreased in
subjects 1 and
5. In subject
2, LVP tonic activity followed the same pattern as the
phasic activity: it increased with hypoxia during the first trial and
decreased during the second trial (Fig. 3).
SPC Response to Chemical Stimulation
SPC phasic activity increased or appeared with increasing PETCO2 in five of nine subjects (subjects 1, 6, and 8-10) (Fig. 4). In subjects 2, 4, and 7, SPC phasic activity remained unchanged with progressive hypercapnia. In subject 5, phasic activity progressively increased until PETCO2 reached 52-54 Torr; it then decreased sharply and started to rise again at the end of the trial. SPC tonic EMG activity increased in response to progressive hypercapnia in subjects 6, 8, and 10. It decreased significantly in subject 2 (P = 0.0001) and remained unchanged in the remaining five subjects (subjects 1, 4, 5, 7, and 9) (Fig. 5). In subjects 6-8 and 10, phasic SPC activity significantly increased with hypoxia (P
0.003). In
subject 5, progressive hypoxia was
accompanied by a significant decrease in phasic SPC EMG
(P = 0.0001). In the remaining three
subjects, hypoxia did not significantly affect SPC phasic activity.
With hypoxia, SPC tonic activity increased in subjects
6, 8, and
9. Progressive hypoxia was accompanied
by a decrease in SPC tonic activity in subject
2. In subject 5, tonic
activity was stable from 100 to 94%, dropped abruptly at ~94%, and
then remained stable at this lower level until the end of the hypoxic
challenge. In subjects 4,
7, and
10, SPC tonic activity did not change
notably with hypoxia.
In these normal awake subjects, we found that, while seldom present during quiet oral breathing, phasic activation of the LVP and SPC appeared during progressive isocapnic hypoxia and hyperoxic hypercapnia. However, in our subjects, respiratory activity in these muscles was characterized by marked inter- and intrasubject variability. EMG responses to chemostimulation were brisk and linear in some individuals and weak or alinear in others. In some subjects, phasic and tonic activity disappeared despite progressive hypoxia and hypercapnia. Some subjects responded to one stimulus but not to the other. Variability was also observed in the phase pattern: most subjects displayed activity during both inspiration and expiration.
Although nonneuromuscular factors influence pharyngeal cross-sectional area, palatal dilator muscle activity is considered to be the main determinant of velopharyngeal patency throughout the respiratory cycle (16). Those dilator muscles are thought to counteract intraluminal subatmospheric pressure by producing phasic inspiratory activity, although the role of tonic activity has recently been stressed (26). Constrictor velopharyngeal muscles have received little attention. However, there is evidence to suggest that their participation in velopharyngeal mechanics should be carefully examined. Velopharyngeal constrictor muscles consist of the LVP and the SPC. Activation of the LVP moves the soft palate rostrally and posteriorly, allowing velopharyngeal closure during swallowing and phonation (7). SPC contraction narrows the velopharynx, and its palatal insertion pulls the soft palate posteriorly (7). Phasic activity has been demonstrated in the SPC during quiet breathing during wakefulness in a previous study (9). LVP respiratory-related activity has also been recorded in normal subjects during quiet breathing (3, 18, 28). Our results confirm the presence of respiratory activity in both muscles. In most previous studies, LVP and SPC respiratory activity appeared to be expiratory (3, 8, 23). However, recent preliminary reports suggest that timing of phasic activity is more variable than previously reported (25, 27). In the present study, phasic activity in both muscles was inspiratory, expiratory, biphasic, or variable. LVP and SPC activation are likely to affect velopharyngeal geometry or mechanics at any point during the respiratory cycle. As the main palatal muscle, LVP regulates route of breathing by modifying soft palate position (3, 7, 27). During oral breathing, inspiratory contraction of the LVP could represent active facilitation of oral airflow. Alternatively, the LVP could be activated during inspiration in response to caudal tug of the soft palate. With increasing respiratory efforts during chemical stimulation, EMG activity would increase to counteract passive stretching. If biomechanical action of the SPC is considered alone, the benefit of inspiratory contraction is not apparent. Data obtained with various preparations suggest, however, that the net mechanical effect of a muscle contraction strongly depends on the activity of other upper airway muscles (1, 5). Synergistic action of the SPC with the LVP, palatoglossus, or palatopharyngeus could, therefore, also tend to decrease resistance to oral airflow. In addition to inspiratory activity, our subjects also demonstrated expiratory activation of the LVP and SPC. Expiratory airflow is, in part, regulated by laryngeal and hypopharyngeal resistance, determined by the combination of abductor muscle relaxation and adductor muscle contraction (5, 15). Further modulation of expiratory flow could be achieved by activation of pharyngeal constrictors. Last, activation of constrictor muscles during expiration may affect velopharyngeal air space by altering the length of dilator muscles and modifying their mechanical action. Contraction of these muscles during expiration decreases the velopharyngeal area, thus affecting inspiratory dynamics. Indeed, it has recently been demonstrated that during wakefulness, minimal airway size is seen at the end of expiration in normal subjects and sleep apnea patients (24). Even in the absence of phasic activation, these muscles could affect the size of the upper airway by the level of their tonic activity. However, in the absence of a biomechanical model of upper airway muscles, the effect of constrictor muscle activation on inspiratory mechanics cannot be predicted.
The variability exhibited by LVP and SPC respiratory activity (variable levels of activation during quiet breathing, amplitude and direction of the response to chemostimulation, timing with respect to the respiratory cycle) raises concerns about the validity of our recordings. We believe, however, that technical difficulties are not likely to account for this variability. Electrodes were inserted following a standard method (8, 9), and preparatory cadaver dissections confirmed that our technique was adequate. Furthermore, the presence of EMG activity during voluntary activation ensured that the wire electrodes were in place. Correct placement of the electrodes was also verified visually at the end of the study, although speech maneuvers were not repeated. We cannot, therefore, exclude the possibility that a wire may have been partially dislodged in some patients. Electrical activity from contiguous muscles is unlikely to explain our findings. At the retropalatal level, the SPC is the sole muscle of the posterior pharyngeal wall. To record from the LVP, electrodes are inserted in the levator dimples. In this area of the velum, fibers from the TVP are tendinous and other palatal muscles insert more laterally (palatoglossus, palatopharyngeus) or more posteriorally (musculus uvulae) than the LVP. We are, therefore, confident that electrodes were properly inserted and that the variability of our data reflects variability in LVP and SPC activity from subject to subject.
Although it has not been reported for the alae nasi, the tensor
palatini, or the genioglossus, inter- and intrasubject variability in
EMG activity have been observed in an animal preparation for the
geniohyoid (30) and in normal human subjects for the thyroarytenoid (15), the arytenoid (14), and, to a lesser degree, for the cricothyroid
(31). Like these muscles, the SPC and the LVP, as highly specialized
muscles active in numerous nonrespiratory functions, are under strong
behavioral control. It is, however, unexpected to find such a degree of
intrasubject variability during chemostimulation, when low behavioral
influences would be anticipated. In the medulla, pharyngeal motoneurons
are located in an area overlapping respiratory centers (4), and
respiratory influences on the pharyngeal motoneurons are suggested by
respiratory-related electrical activity recorded in pharyngeal muscles.
However, suprapontine influences are likely to be predominant in the
regulation of these motoneurons, which are involved in voluntary
activities such as speech production or swallowing. Discomfort due to
the mouthpiece, the nose clips, or hyperventilation may have resulted
in behavioral control overriding automatic control of palatal
musculature, allowing some subjects to modify the position of their
palate. Indeed, during a different experimental protocol, we have
observed the effect of discomfort caused by a thin nasopharyngoscope on
the LVP EMG activity in subject 10:
while he was complaining of discomfort, tonic activity was near maximum
value; after adjustment of the scope and relief of discomfort, tonic
activity decreased sharply by 75% (unpublished observations). Such
abrupt changes in tonic activity were observed during this study in
subjects 3 and
5. Furthermore, in
subject 3, when the level of tonic
activity decreased, phasic activity was "unmasked" (Fig.
6). It is, therefore, possible that phasic
response to chemostimulation was obscured by high tonic activity in
some subjects. Last, tongue and jaw position were not fixed during the
course of the experiment. Given the close interactions between
pharyngeal muscles, movements of either of these structure are likely
to modify the activity of the SPC and LVP (13). Non-rapid-eye-movement
(NREM) sleep provides an opportunity to examine the relative
contribution of suprapontine influences and "peripheral" or
anatomic factors (jaw or tongue position, for instance) to the
variability in muscle activity. There are, however, few data available
at the present time. In the only study of SPC activity during sleep,
Sauerland et al. (23) observed the persistence of SPC phasic activity
in NREM but also noted that this activity could be intermittent in some (but not all) subjects. Tangel et al. (29) reported a consistent decrease in peak LVP activity during NREM sleep, although the amplitude
of the decrease was somewhat variable. The issue of possible EMG
variability was not addressed in either study, and an experimental
protocol aimed at investigating how vigilance affects EMG variability
may yield important information.
Variable phase pattern was observed in our subjects for the SPC and the LVP. Similar findings have been reported in animal models and normal adults. In dogs, pharyngeal constrictors are active during expiration but can exhibit inspiratory activity as well (11). In decerebrate artificially ventilated cats, glossopharyngeal motoneurons display inspiratory discharge only, whereas both inspiratory and expiratory bursts are present in the pharyngeal branches of the vagus (4). In normal subjects, during progressive hypercapnia, posterior cricoarytenoid inspiratory activity can be prolonged and persists after the beginning of expiration (2). Previous studies did not show any variability in the relationship of LVP or SPC activity to the respiratory cycle (3, 9, 18, 23, 28). Differences in species, body position, route of breathing, or chemical drive could account for the discrepancy among studies. The significance of shifts in phase pattern of pharyngeal muscles remains unclear.
In conclusion, velopharyngeal constrictors display respiratory activity and respond to chemostimulation. Their electrical activity is remarkably variable, and we suggest that this variability results from strong behavioral influences on pharyngeal motoneurons supplying these muscles. Additional studies of velopharyngeal muscle activity during wakefulness and sleep may provide further evidence of the role of these suprapontine influences.
At this stage, we can only speculate on how the variability that we observed in EMG activity may affect velopharyngeal function. This variability in velopharyngeal musculature activity is likely to contribute to the absence of a consistent relationship between palatal muscle activity and velopharyngeal patency that our laboratory has reported recently in normal awake adults (17). If one assumes that velopharyngeal muscles determine velopharyngeal patency, variable EMG activation would require multiple interaction patterns between local and regional muscles to maintain velopharyngeal patency while behavioral and anatomical factors fluctuate.
Last, the findings of this study should encourage future investigators to take variable EMG activity into account when investigating palatal muscle contribution to transpalatal resistance and velopharyngeal narrowing during sleep.
This work was supported by National Heart, Lung, and Blood Institute Grant HL-46951. S. H. Launois is a fellow in the Clinical Investigator Training Program: Beth Israel Hospital-Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer, Inc.
Address for reprint requests: S. H. Launois, Pulmonary Div., Dept. of Medicine, Beth Israel Hospital Boston, 330 Brookline Ave., Boston MA 02115 (E-mail: slaunois{at}bidmc.harvard.edu).
Received 27 February 1996; accepted in final form 10 September 1996.
| 1. |
Amis, T. C.,
A. Brancatisano,
A. Tully,
and
L. A. Engel.
Pharyngeal dilation associated with cricothyroid muscle contraction in dogs.
J. Appl. Physiol.
73:
762-766,
1992.
|
| 2. | Bartlett, D. J., J. E. Remmers, and H. Gautier. Laryngeal regulation of respiratory airflow. Respir. Physiol. 18: 194-204, 1973. [Medline] |
| 3. | Basner, R., J. Lilly, E. Garpestad, R. Schwartzstein, and J. W. Weiss. Differential activity of levator and tensor veli palatini related to breathing route (Abstract). Am. Rev. Respir. Dis. 143: A791, 1991. |
| 4. | Bianchi, A. L., L. Grelot, and J. C. Barillot. Motor output to the pharyngeal muscles. Prog. Clin. Biol. Res. 345: 89-97, 1990. [Medline] |
| 5. | Brancatisano, A., and L. A. Engel. Role of the upper airway in the control of respiratory flow and lung volume in humans. In: Respiratory Function of the Upper Airway, edited by O. P. Matthew, and G. Sant'Ambrogio. New York: Dekker, 1988, vol. 35, p. 447-517. (Lung Biol. Health Ser.) |
| 6. |
Carlson, D. M.,
D. W. Carley,
E. Onal,
M. Lopata,
and
R. C. Basner.
Acoustically induced cortical arousal increases phasic pharyngeal muscle and diaphragmatic EMG in NREM sleep.
J. Appl. Physiol.
76:
1553-1559,
1994.
|
| 7. | Fritzell, B. The velopharyngeal muscles in speech. An electromyographic and cineradiographic study. Acta Oto-Laryngol. Suppl. 250: 1-81, 1969. |
| 8. | Hairston, L. E., and E. K. Sauerland. Electromyography of the human palate: discharge patterns of the levator and tensor veli palatini. Electromyogr. Clin. Neurophysiol. 21: 287-297, 1981. [Medline] |
| 9. | Hairston, L. E., and E. K. Sauerland. Electromyography of the human pharynx: discharge patterns of the superior pharyngeal constrictor during respiration. Electromyogr. Clin. Neurophysiol. 21: 299-306, 1981. [Medline] |
| 10. |
Hudgel, D. W.,
and
C. Hendricks.
Palate and hypopharynx sites of inspiratory narrowing of the upper airway during sleep.
Am. Rev. Respir. Dis.
138:
1542-1547,
1988.
[Medline]
|
| 11. | Kawasaki, M., J. H. Ogura, and S. Takenouchi. Neurophysiologic observations of normal deglutition. I. Its relationship to the respiratory cycle. Laryngoscope 74: 1747-1765, 1964. |
| 12. | Kogo, M., J. Nishio, T. Matsuya, Y. Hamamura, and T. Miyaaki. Coordination of the levator veli palatini and intrinsic laryngeal muscles: an evoked electromyographic study in the dog. Cleft Palate J. 24: 119-125, 1987. [Medline] |
| 13. | Kuehn, D. P., J. W. Folkins, and C. B. Cutting. Relationships between muscle activity and velar position. Cleft Palate J. 19: 25-35, 1982. [Medline] |
| 14. |
Kuna, S. T.,
G. Insalaco,
D. R. Villeponteaux,
C. R. Vanoye,
and
J. S. Smickley.
Effect of hypercapnia and hypoxia on arytenoideus muscle activity in normal adult humans.
J. Appl. Physiol.
75:
1781-1789,
1993.
|
| 15. |
Kuna, S. T.,
G. Insalaco,
and
G. E. Woodson.
Thyroarytenoid muscle activity during wakefulness and sleep in normal adults.
J. Appl. Physiol.
65:
1332-1339,
1988.
|
| 16. | Kuna, S. T., and G. Sant'Ambrogio. Pathophysiology of upper airway closure during sleep. JAMA 266: 1384-1389, 1991. [Abstract] |
| 17. |
Launois, S. H.,
S. Remsburg,
W. J. Yang,
and
J. W. Weiss.
Relationship between velopharyngeal dimensions and palatal EMG during progressive hypercapnia.
J. Appl. Physiol.
80:
478-485,
1996.
|
| 18. | Lilly, J., R. Basner, E. Garpestad, and J. W. Weiss. Activity of "antagonist" soft palate muscles in awake and sleeping normals (Abstract). Am. Rev. Respir. Dis. 143: A792, 1991. |
| 19. | Morrison, D. L., S. H. Launois, S. Isono, T. R. Feroah, W. A. Whitelaw, and J. E. Remmers. Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea. Am. Rev. Respir. Dis. 148: 606-611, 1993. [Medline] |
| 20. | Mortimore, I. L., R. Mathur, and N. J. Douglas. Effect of posture and negative pressure application on levator palatini and palatoglossus muscle activity (Abstract). Am. J. Respir. Crit. Care Med. 149: A145, 1994. |
| 21. | Read, D. J. C. A clinical method for assessing the ventilatory response to carbon dioxide. Australas. Ann. Med. 16: 20-32, 1966. |
| 22. | Rebuck, A. S., and E. J. Campbell. A clinical method for assessing the ventilatory response to hypoxia. Am. Rev. Respir. Dis. 109: 345-350, 1974. [Medline] |
| 23. | Sauerland, E. K., W. C. Orr, and L. E. Hairston. EMG patterns of oropharyngeal muscles during respiration in wakefulness and sleep. Electromyogr. Clin. Neurophysiol. 21: 307-316, 1981. [Medline] |
| 24. | Schwab, R. J., W. B. Gefter, E. A. Hoffman, K. B. Gupta, and A. I. Pack. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am. Rev. Respir. Dis. 148: 1385-1400, 1993. [Medline] |
| 25. | Smickley, J. S., and S. T. Kuna. Respiratory-related activity of the pharyngeal constrictor muscles during wakefulness and sleep in normal adult humans (Abstract). Am. J. Respir. Crit. Care Med. 151: A556, 1995. |
| 26. |
Tangel, D. J.,
W. S. Mezzanotte,
E. J. Sandberg,
and
D. P. White.
Influence of NREM sleep on the activity of tonic vs. inspiratory phasic muscles in normal men.
J. Appl. Physiol.
73:
1058-1066,
1992.
|
| 27. | Tangel, D. J., W. S. Mezzanotte, J. R. Wheatley, and D. P. White. The effect of route of respiration on palatoglossus and levator muscle activity (Abstract). Am. Rev. Respir. Dis. 145: A411, 1992. |
| 28. | Tangel, D. J., W. S. Mezzanotte, and D. P. White. NREM sleep effect on levator palatini and palatoglossus muscle function in normal subjects (Abstract). Am. Rev. Respir. Dis. 147: A766, 1993. |
| 29. |
Tangel, D. J.,
W. S. Mezzanotte,
and
D. P. White.
Influences of NREM sleep on activity of palatoglossus and levator palatini muscles in normal men.
J. Appl. Physiol.
78:
689-695,
1995.
|
| 30. | Van Lunteren, E., and T. E. Dick. Breath-to-breath variability in hypoglossal motor unit firing. Respir. Physiol. 89: 37-46, 1992. [Medline] |
| 31. |
Wheatley, J. R.,
A. Brancatisano,
and
L. A. Engel.
Cricothyroid muscle responses to increased chemical drive in awake normal humans.
J. Appl. Physiol.
70:
2233-2241,
1991.
|
This article has been cited by other articles:
![]() |
ATS/ERS Statement on Respiratory Muscle Testing Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 518 - 624. [Full Text] [PDF] |
||||
![]() |
T. C. Amis, N. O'Neill, J. R. Wheatley, T. van der Touw, E. di Somma, and A. Brancatisano Soft palate muscle responses to negative upper airway pressure J Appl Physiol, February 1, 1999; 86(2): 523 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Kuna and C. R. Vanoye Mechanical effects of pharyngeal constrictor activation on pharyngeal airway function J Appl Physiol, January 1, 1999; 86(1): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Kuna and C. R. Vanoye Respiratory-related pharyngeal constrictor muscle activity in decerebrate cats J Appl Physiol, November 1, 1997; 83(5): 1588 - 1594. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |